Published in Transl Neurodegener on May 24, 2013
Parkinsonism: onset, progression and mortality. Neurology (1967) 36.06
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (2003) 6.59
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72
How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology (2003) 3.11
Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord (1999) 2.98
STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology (2008) 2.93
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord (2007) 1.82
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain (2010) 1.66
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol (2011) 1.65
Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology (2001) 1.61
Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease. J Neurosurg (2005) 1.13
STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology (2009) 0.94
Differential progression of motor impairment in levodopa-treated Parkinson's disease. Mov Disord (2000) 0.91
Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp Neurol (2001) 0.89
Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation. Brain (2002) 0.82